Alpha Jack
Natural health product licensed in Canada
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80086584
- Status
- Active licence
- Licence date
- 25 June 2018
- Revision date
- 15 March 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ophiocordyceps sinensis Source : Stroma | 50 milligramme | Not calculated |
| Shilajit Source : Shilajit | 41.67 milligramme | Not calculated |
| Lepidium meyenii Source : Racine | 33.3 milligramme | Not calculated |
| Acide D-aspartique Source : Acide D-aspartique | 500 milligramme | Not calculated |
| Eurycoma longifolia Source : Racine | 66.67 milligramme | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 days |
Uses authorised in Canada
Source of fungal polysaccharides with immunomodulating properties. Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. Consult a healthcare practitioner prior to use if you have benign prostate hypertrophy and/or prostate cancer. Consult a healthcare practitioner prior to use if you are taking propranolol. Adult women: Consult a healthcare practitioner if you experience abnormal hair growth.
Source
Official Health Canada record, licence 80086584
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.